Related Experiment Video
Updated: Aug 21, 2026

Prion Safety Laboratory Swipe Test
Published on: February 14, 2025
Variant Creutzfeldt-Jakob disease
1National CJD Surveillance Unit, Western General Hospital, Edinburgh, Scotland, UK. r.g.will@ed.ac.uk
Insights
Variant Creutzfeldt-Jakob disease (vCJD) in humans is linked to bovine spongiform encephalopathy. While vCJD cases may have peaked, the risk of transmission through blood transfusions remains a concern.
Area of Science:
- Neuroscience
- Epidemiology
- Infectious Diseases
Background:
- Variant Creutzfeldt-Jakob disease (vCJD) is understood to result from the transmission of bovine spongiform encephalopathy (BSE) to humans.
- vCJD presents distinct clinical, investigative, and neuropathological features compared to sporadic CJD.
- The epidemiology of vCJD, particularly in the UK, suggests a potential peak in cases, though future numbers remain uncertain.
Purpose of the Study:
- To summarize the current understanding of variant Creutzfeldt-Jakob disease.
- To highlight the distinct characteristics of vCJD compared to other forms of CJD.
- To address the uncertainty surrounding future vCJD case numbers and potential transmission routes.
Main Methods:
- Review of current scientific evidence and literature.
- Comparative analysis of clinical and pathological data for vCJD and sporadic CJD.
- Epidemiological assessment of vCJD case trends.
Main Results:
- Evidence strongly supports BSE transmission as the cause of vCJD.
- vCJD exhibits unique clinical and neuropathological profiles.
- Recent identification of iatrogenic transmission via blood transfusion poses a new public health challenge.
Conclusions:
- The causal link between BSE and vCJD is established.
- The distinct nature of vCJD necessitates specific diagnostic and surveillance strategies.
- Ongoing vigilance is crucial due to the uncertain future incidence and the risk of secondary transmission.
Abstract:
Current evidence indicates that variant Creutzfeldt-Jakob disease is caused by the transmission of bovine spongiform encephalopathy to humans. The clinical and investigative features of variant CJD are relatively distinct from sporadic CJD and the neuropathological appearances are novel. The number of cases of vCJD in the UK may have peaked, but the total future number of cases of vCJD is uncertain and the possibility of secondary iatrogenic transmission via blood transfusion has recently been identified.
Related Concept Videos
Cryptococcal Meningitis
Huntington Disease l: Introduction
Cytomegalovirus Disease
Alzheimer Disease ll: Pathophysiology
Arboviral Encephalitis
Encephalitis ll: Pathophysiology

